Product Specifications
| Specification | Details |
| Manufacturer / Brand | Baxter Anesthetic & Critical Care |
| Manufacturer # / SKU | 3600032202 |
| Product Type | Antihypertensive / Beta-Blocker |
| Active Ingredient | Labetalol Hydrochloride |
| Concentration | 5 mg / mL |
| Total Volume | 20 mL (100 mg total) |
| Dosage Form | Injection Solution |
| Container Type | Multiple-Dose Vial (MDV) |
| Route of Administration | Intravenous (IV) |
| Equivalent To | Normodyne® / Trandate® |
| Packaging / Sold As | 1 Vial per Box (Individually Boxed) |
| NDC Number | 36000-0322-02 |
| UNSPSC Code | 51260000 |
Key Features
-
Dual Action Blocking: Acts as a mixed alpha/beta-adrenergic antagonist to effectively lower peripheral vascular resistance and blood pressure.
-
Rapid Onset: Engineered for intravenous use to provide quick blood pressure reduction in critical and emergency care settings.
-
MDV Efficiency: The 20 mL multiple-dose vial includes preservatives, allowing for repeated access and precise, customizable dosing based on patient weight and response.
-
Controlled Alkalinity: Formulated with a pH-adjusted solution (using citric acid or sodium hydroxide) to ensure stability and compatibility during IV administration.
-
Prescription Reliability: A trusted generic equivalent to brand-name Normodyne® and Trandate® for cardiovascular management.
